SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-21-001784
Filing Date
2021-09-13
Accepted
2021-09-13 16:04:34
Documents
14
Period of Report
2021-09-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K elym-20210913.htm   iXBRL 8-K 71713
2 EX-99.1 elym-20210913ex99_1.htm EX-99.1 37735
3 GRAPHIC img212067570_0.jpg GRAPHIC 60643
  Complete submission text file 0000950170-21-001784.txt   329325

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT elym-20210913_pre.xml EX-101.PRE 11622
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT elym-20210913.xsd EX-101.SCH 2494
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT elym-20210913_lab.xml EX-101.LAB 18564
7 EXTRACTED XBRL INSTANCE DOCUMENT elym-20210913_htm.xml XML 4906
Mailing Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053
Business Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053 425-276-2300
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40708 | Film No.: 211249659
SIC: 2834 Pharmaceutical Preparations